Bone morphogenetic agents
Patent 4795804 Issued on January 3, 1989. Estimated Expiration Date: 
January 3, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 3, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2384673 2717835 3539549 3887717 Novel glycoproteins from bovine cartilage Bone morphogenetic protein process Bone graft material for osseous defects and method of making same Partially purified osteogenic factor and process for preparing same from demineralized bone Bone morphogenetic protein Thrombin-binding substance and process for its production Patent #: 4638050 InventorAssigneeApplicationNo. 06/763479 filed on 08/07/1985US Classes:530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES514/12, 25 or more peptide repeating units in known peptide chain structure514/21, Produced by or extracted from animal tissue530/355, Separation, purification or synthesis530/356, Collagen530/417, Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.530/840, Bones; tendons; teeth; cartilage930/10PEPTIDE OR PROTEIN SEQUENCEExaminersPrimary: Foelak, MortonAssistant: Nutter, Nathan M. Attorney, Agent or FirmInternational ClassesC07K 14/435 (20060101)C07K 14/51 (20060101) A61K 38/00 (20060101) AbstractThe production and isolation of bone morphogenetic peptide agents displaying the osteoinductive and immunoreactive activity of bone morphogenetic protein (BMP) and deriving from natural, synthetic or recombinant DNA sources, and said agents.Other References
|
| ||||||||||||||
